catechin has been researched along with lovastatin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Popovich, DG; Tiaras, F; Yeo, CR; Zhang, W | 1 |
| Guan, BX; Xu, XC; Ye, F; Zhang, GH | 1 |
| Chang, HH; Chang, JZ; Deng, YT; Kuo, MY; Liu, CM; Yang, WH | 1 |
| Chen, YW; Hsieh, WL; Lai, CH; Lee, BS; Lee, CC; Lin, HP; Shih, WA; Takeuchi, Y | 1 |
| Kawaguchi, Y; Kitamura, K; Nagaoka, S; Okada, K; Okada, Y | 1 |
6 other study(ies) available for catechin and lovastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Lovastatin interacts with natural products to influence cultured hepatocarcinoma cell (hep-g2) growth.
Topics: Antineoplastic Agents; Capsaicin; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cells, Cultured; Curcumin; Drug Synergism; Hep G2 Cells; Herb-Drug Interactions; Humans; Liver Neoplasms; Lovastatin; Plant Extracts | 2010 |
Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.
Topics: Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Catechin; Cell Line, Tumor; Curcumin; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Esophageal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Lovastatin; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 2012 |
Curcumin inhibits TGFβ1-induced CCN2 via Src, JNK, and Smad3 in gingiva.
Topics: Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Catechin; Cell Culture Techniques; Cell Movement; Cells, Cultured; Connective Tissue Growth Factor; Curcumin; Enzyme Inhibitors; Fibroblasts; Flavonoids; Gingiva; Gingival Overgrowth; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Lovastatin; MAP Kinase Kinase 4; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Signal Transduction; Smad3 Protein; src-Family Kinases; Transforming Growth Factor beta1 | 2013 |
A functional chitosan membrane with grafted epigallocatechin-3-gallate and lovastatin enhances periodontal tissue regeneration in dogs.
Topics: Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Catechin; Cell Adhesion; Cell Proliferation; Chitosan; Delayed-Action Preparations; Dogs; Drug Carriers; Drug Liberation; Fibroblasts; Gingiva; Guided Tissue Regeneration; Humans; Lovastatin; Male; Membranes, Artificial; Tensile Strength | 2016 |
Epigallocatechin gallate induces an up-regulation of LDL receptor accompanied by a reduction of PCSK9 via the annexin A2-independent pathway in HepG2 cells.
Topics: Annexin A2; Catechin; Gene Expression Regulation; Gene Knockdown Techniques; Hep G2 Cells; Humans; Lipoproteins, LDL; Lovastatin; MAP Kinase Signaling System; Proprotein Convertase 9; Receptors, LDL; Up-Regulation | 2017 |